Literature DB >> 26935860

Regulatory mechanisms of EGFR signalling during Drosophila eye development.

Marianne Malartre1.   

Abstract

EGFR signalling is a well-conserved signalling pathway playing major roles during development and cancers. This review explores what studying the EGFR pathway during Drosophila eye development has taught us in terms of the diversity of its regulatory mechanisms. This model system has allowed the identification of numerous positive and negative regulators acting at specific time and place, thus participating to the tight control of signalling. EGFR signalling regulation is achieved by a variety of mechanisms, including the control of ligand processing, the availability of the receptor itself and the transduction of the cascade in the cytoplasm. Ultimately, the transcriptional responses contribute to the establishment of positive and negative feedback loops. The combination of these multiple mechanisms employed to regulate the EGFR pathway leads to specific cellular outcomes involved in functions as diverse as the acquisition of cell fate, proliferation, survival, adherens junction remodelling and morphogenesis.

Entities:  

Keywords:  Activators; Combinatorial signalling; Drosophila; EGFR; Inhibitors; Ommatidia; Photoreceptors; Retina

Mesh:

Substances:

Year:  2016        PMID: 26935860     DOI: 10.1007/s00018-016-2153-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  141 in total

Review 1.  EGF receptor signaling: putting a new spin on eye development.

Authors:  Tanya Wolff
Journal:  Curr Biol       Date:  2003-10-14       Impact factor: 10.834

2.  EGF signaling and ommatidial rotation in the Drosophila eye.

Authors:  Helen Strutt; David Strutt
Journal:  Curr Biol       Date:  2003-08-19       Impact factor: 10.834

3.  Echinoid regulates Flamingo endocytosis to control ommatidial rotation in the Drosophila eye.

Authors:  Yu-Huei Ho; Mong-Ting Lien; Chiao-Ming Lin; Shu-Yi Wei; Li-Hsun Chang; Jui-Chou Hsu
Journal:  Development       Date:  2010-01-28       Impact factor: 6.868

4.  The Drosophila Arf GEF Steppke controls MAPK activation in EGFR signaling.

Authors:  Ines Hahn; Bernhard Fuss; Annika Peters; Tamara Werner; Andrea Sieberg; Dominic Gosejacob; Michael Hoch
Journal:  J Cell Sci       Date:  2013-04-02       Impact factor: 5.285

5.  Trafficking of the EGFR ligand Spitz regulates its signaling activity in polarized tissues.

Authors:  Josefa Steinhauer; Hui Hua Liu; Eli Miller; Jessica E Treisman
Journal:  J Cell Sci       Date:  2013-07-31       Impact factor: 5.285

6.  Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases.

Authors:  S Urban; J R Lee; M Freeman
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

7.  Regulation of EGFR and Notch signaling by distinct isoforms of D-cbl during Drosophila development.

Authors:  Yuan Wang; Zhihong Chen; Andreas Bergmann
Journal:  Dev Biol       Date:  2010-03-17       Impact factor: 3.582

Review 8.  The status and role of ErbB receptors in human cancer.

Authors:  I Uberall; Z Kolár; R Trojanec; J Berkovcová; M Hajdúch
Journal:  Exp Mol Pathol       Date:  2008-01-05       Impact factor: 3.362

9.  Sprouty: a common antagonist of FGF and EGF signaling pathways in Drosophila.

Authors:  S Kramer; M Okabe; N Hacohen; M A Krasnow; Y Hiromi
Journal:  Development       Date:  1999-06       Impact factor: 6.868

10.  Epithelial cell adhesion in the developing Drosophila retina is regulated by Atonal and the EGF receptor pathway.

Authors:  Katherine E Brown; Antonio Baonza; Matthew Freeman
Journal:  Dev Biol       Date:  2006-08-09       Impact factor: 3.582

View more
  12 in total

Review 1.  Cell-Cell Contact and Receptor Tyrosine Kinase Signaling.

Authors:  Christine Chiasson-MacKenzie; Andrea I McClatchey
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  Expression of Mammalian BM88/CEND1 in Drosophila Affects Nervous System Development by Interfering with Precursor Cell Formation.

Authors:  Athanasios Tzortzopoulos; Dimitra Thomaidou; Maria Gaitanou; Rebecca Matsas; Efthimios Skoulakis
Journal:  Neurosci Bull       Date:  2019-05-11       Impact factor: 5.203

3.  EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis.

Authors:  Jennifer Soler Beatty; Cristina Molnar; Carlos M Luque; Jose F de Celis; María D Martín-Bermudo
Journal:  PLoS Genet       Date:  2021-08-19       Impact factor: 5.917

4.  Mask, a component of the Hippo pathway, is required for Drosophila eye morphogenesis.

Authors:  Miles W DeAngelis; Emily W McGhie; Joseph D Coolon; Ruth I Johnson
Journal:  Dev Biol       Date:  2020-05-25       Impact factor: 3.582

5.  Novel interplay between JNK and Egfr signaling in Drosophila dorsal closure.

Authors:  Tatyana Kushnir; Sharon Mezuman; Shaked Bar-Cohen; Rotem Lange; Ze'ev Paroush; Aharon Helman
Journal:  PLoS Genet       Date:  2017-06-19       Impact factor: 5.917

Review 6.  Epidermal Growth Factor Pathway Signaling in Drosophila Embryogenesis: Tools for Understanding Cancer.

Authors:  Jay B Lusk; Vanessa Y M Lam; Nicholas S Tolwinski
Journal:  Cancers (Basel)       Date:  2017-02-07       Impact factor: 6.639

7.  Comparative transcriptome analyses of the Drosophila pupal eye.

Authors:  Miles W DeAngelis; Joseph D Coolon; Ruth I Johnson
Journal:  G3 (Bethesda)       Date:  2021-01-18       Impact factor: 3.154

8.  EGFR controls Drosophila tracheal tube elongation by intracellular trafficking regulation.

Authors:  Ivette Olivares-Castiñeira; Marta Llimargas
Journal:  PLoS Genet       Date:  2017-07-05       Impact factor: 5.917

9.  A screen for E3 ubiquitination ligases that genetically interact with the adaptor protein Cindr during Drosophila eye patterning.

Authors:  Kwami F Ketosugbo; Henry L Bushnell; Ruth I Johnson
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

Review 10.  Modelling Cooperative Tumorigenesis in Drosophila.

Authors:  Helena E Richardson; Marta Portela
Journal:  Biomed Res Int       Date:  2018-03-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.